What does it mean for India? The Indian version of Oxford-AstraZeneca COVID-19 vaccine is known as Covishield.
Serum Institute of India, the world's largest vaccine manufacturer by volume, joined hands with AstraZeneca to produce 1 billion doses of its COVID-19 vaccine.
Several countries have ordered the vaccine from SII.Following the suspension of the vaccine by several countries, the central government has decided to conduct a deeper review of post-vaccination side-effects from the Oxford-AstraZeneca coronavirus vaccine, as per a news report by AFP on Saturday. "We are looking at all the adverse events, particularly serious adverse events like deaths and hospitalisation.